Edesa Biotech, Inc.
EDSA
$2.43
$0.010.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.13% | -14.68% | -15.39% | -6.68% | 14.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.08% | -23.94% | -18.91% | -23.94% | -13.51% |
| Operating Income | 23.08% | 23.94% | 18.91% | 23.94% | 13.51% |
| Income Before Tax | 14.57% | 19.42% | 20.85% | 26.32% | 26.83% |
| Income Tax Expenses | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 14.56% | 19.42% | 20.85% | 26.32% | 26.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.56% | 19.42% | 20.85% | 26.32% | 26.82% |
| EBIT | 23.08% | 23.94% | 18.91% | 23.94% | 13.51% |
| EBITDA | 22.98% | 23.87% | 19.15% | 24.43% | 13.86% |
| EPS Basic | 39.77% | 32.47% | 27.68% | 34.51% | 38.97% |
| Normalized Basic EPS | 43.82% | 33.90% | 23.87% | 31.41% | 27.80% |
| EPS Diluted | 39.77% | 32.47% | 27.68% | 34.51% | 38.97% |
| Normalized Diluted EPS | 43.82% | 33.90% | 23.87% | 31.41% | 27.80% |
| Average Basic Shares Outstanding | 50.53% | 23.14% | 8.95% | 11.82% | 17.48% |
| Average Diluted Shares Outstanding | 50.53% | 23.14% | 8.95% | 11.82% | 17.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |